• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

June 24, 2021

Study: New Link Between High Fat Diet, Colon Cancer

Author(s):

Jill Murphy, Associate Editor

Further, the ISCs reside in a series of regularly folded valleys of the gut, which the researchers call crypts.

A new study led by researchers at Arizona State University indicates that a diet high in fat can trigger a series of molecular events that can cause intestinal and colon cancer, as published in the journal Cell Reports.

When foods break down and move through the gut, they interact with intestinal stem cells (ISC) along the inner surfaces of the gut. Further, the ISCs reside in a series of regularly folded valleys of the gut, which the researchers call crypts.

ISCs are thought to be the gateway that coordinates intestinal tumor formation during adaptation to high-fat diets, thus elevating the risk of cancer. High-fat sensor molecules lie within the ISCs, which help sense and react to high-fat diet levels in the cells, according to the study.

"We were following up on mechanisms that might be required for stem cells to adapt to the high fat diet—and that's where we came across the [peroxisome proliferator-activated receptors (PPARs)]," said researcher Miyeko Mana in the press release.

She added that PPARs activate a cellular program that increases the risk of cancer. However, the exact mechanisms were unclear because there are multiple types of PPARs and complexities in teasing out their roles, according to the study.

Mana and her team explored the role of individual PPAR delta and alpha using a mouse model that controlled their activity in the cell. The mice were given a long-term fat or normal diet, with the activity of each PPAR carefully monitored to evaluate the effects on cancer risk.

The team first removed the PPAR delta gene, and the team observed the phenotype after removing it from the intestine to analyze whether another PPAR was compensating due to the high-fat diet phenotype within the stem cells, according to the study authors.

Mana and her team continued to test the genetic complex by slowly teasing out the details, including the level of molecular sequencing from individual cells from different areas of the small intestine and colon. They then used mass spectrometry to measure the amounts of different metabolites.

"So, we looked more downstream at what these two factors (PPARs) may target, and that was this mitochondrial protein, Cpt1a," Mana said in the press release. "This is required for the import of long chain fatty acids (LCFAs) into mitochondria for use. The LCFAs are part of the high fat diet."

When the study authors conducted the mouse knockout study of Cpt1a, they found tumor formation could he stopped and the loss of Cpt1a prevented both the expansion and proliferation of the ISCs in the crypts.

"If you remove Cpt1a, you are spared this high fat diet phenotype in the intestinal stem cells," Mana said in the press release. "So, you lower your risk of tumorigenesis at this point."

Some of the findings include that free fatty acids that help stimulate sensors, such as PPARs, activate genes that can break down the fatty acids and the ability of mutations to occur when the ISCs numbers expand, leading to colon cancer.

"The idea is that this larger pool of cells remain in the intestine and accumulate mutations, and that means they can be a source of mutated cells leading to transformation and tumor initiation," Mana said in the press release. "We do think that is a likely possibility when there are conditions that expand your stem cell pool."

The team also discovered that consuming a high fat diet dramatically accelerated mortality in this model compared with the control condition by accelerating tumorigenesis, according to the study.

"The levels of these fats that you can get through your diet are going to impact your stem cells, probably in a fairly direct way," Mana said in the press release. "I think one of the surprising things we are finding in our studies is that fatty acids can have such a direct effect. But you can remove these PPARs, you can remove CPT1a, and the intestine is fine."

The team hopes that this new evidence can help to expand future work for human colon cancers.

"These studies have all been in these mouse models to date," Mana said in the press release. "One idea we started with was to understand the metabolic dependencies of the tumors that can arise in a natural or pharmacological context and then target these metabolic programs to the detriment of the tumor but not the normal tissue. We are making progress with the high fat diet model. Ultimately though, the goal is to eliminate or prevent colorectal cancer in humans."

REFERENCE

Study shows new links between high fat diets and colon cancer. EurekAlert! Published June 9, 2021. Accessed June 11, 2021. https://www.eurekalert.org/pub_releases/2021-06/asu-ssn060921.php

Related Videos
Image credit: Dr_Microbe | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Related Content
Advertisement
Sample of cancer cells on petri dish | Image Credit: © Ricardo MzF .com - stock.adobe.com
May 30th 2025

Novel Agents, Promising Data: The Evolving Landscape of Oncology Care

Alexandra Gerlach, Associate Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
TKIs binding to target proteins | Image Credit: © Justlight - stock.adobe.com
May 30th 2025

Patient Reported Outcomes Show Improved Symptoms With Zongertinib for HER2-Mutated Non-Small Cell Lung Cancer

Alexandra Gerlach, Associate Editor
pharmacy focus oncology podcast
May 19th 2025

Insights from a Pharmacy Times Peer Exchange: Real-World Outcomes and Supportive Care

Alexandra Gerlach, Associate Editor
ASCO 2025: Pretreatment DPYD Testing for Fluoropyrimidines Can Improve Patient Safety and Lower Cost
May 29th 2025

ASCO 2025: Pretreatment DPYD Testing for Fluoropyrimidines Can Improve Patient Safety and Lower Cost

Alana Hippensteele, Lead Editor
Model of a kidney depicting CKD -- Image credit: kanruthai | stock.adobe.com
May 29th 2025

Childhood Cancer Survivors at an Increased Risk of Developing CKD, Study Finds

Gillian McGovern, Associate Editor
Related Content
Advertisement
Sample of cancer cells on petri dish | Image Credit: © Ricardo MzF .com - stock.adobe.com
May 30th 2025

Novel Agents, Promising Data: The Evolving Landscape of Oncology Care

Alexandra Gerlach, Associate Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
TKIs binding to target proteins | Image Credit: © Justlight - stock.adobe.com
May 30th 2025

Patient Reported Outcomes Show Improved Symptoms With Zongertinib for HER2-Mutated Non-Small Cell Lung Cancer

Alexandra Gerlach, Associate Editor
pharmacy focus oncology podcast
May 19th 2025

Insights from a Pharmacy Times Peer Exchange: Real-World Outcomes and Supportive Care

Alexandra Gerlach, Associate Editor
ASCO 2025: Pretreatment DPYD Testing for Fluoropyrimidines Can Improve Patient Safety and Lower Cost
May 29th 2025

ASCO 2025: Pretreatment DPYD Testing for Fluoropyrimidines Can Improve Patient Safety and Lower Cost

Alana Hippensteele, Lead Editor
Model of a kidney depicting CKD -- Image credit: kanruthai | stock.adobe.com
May 29th 2025

Childhood Cancer Survivors at an Increased Risk of Developing CKD, Study Finds

Gillian McGovern, Associate Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.